TMC Life Sciences Berhad (KLSE:TMCLIFE)
Malaysia
· Delayed Price · Currency is MYR 0.450
+0.015 (3.45%)
At close: Dec 4, 2025
TMC Life Sciences Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 364.05 | 345.54 | 346.42 | 311.44 | 243.77 | 201.02 | Upgrade
|
| Other Revenue | 0.1 | 0.1 | - | 0.11 | - | - | Upgrade
|
| Revenue | 364.14 | 345.63 | 346.42 | 311.56 | 243.77 | 201.02 | Upgrade
|
| Revenue Growth (YoY) | 8.39% | -0.23% | 11.19% | 27.81% | 21.27% | 9.20% | Upgrade
|
| Cost of Revenue | 246.88 | 235.97 | 208.4 | 185.5 | 155.89 | 131.52 | Upgrade
|
| Gross Profit | 117.26 | 109.67 | 138.02 | 126.06 | 87.88 | 69.5 | Upgrade
|
| Other Operating Expenses | 66.42 | 63.36 | 52.75 | 53 | 39.94 | 30.65 | Upgrade
|
| Operating Expenses | 102.65 | 97.46 | 80.66 | 79.01 | 55.79 | 43.67 | Upgrade
|
| Operating Income | 14.61 | 12.21 | 57.36 | 47.05 | 32.09 | 25.84 | Upgrade
|
| Interest Expense | -8.96 | -9.32 | -10.25 | -9.4 | -2.09 | -0.44 | Upgrade
|
| Interest & Investment Income | 3.51 | 4.17 | 5.47 | 3.25 | 2 | 2.19 | Upgrade
|
| EBT Excluding Unusual Items | 9.17 | 7.06 | 52.58 | 40.89 | 32 | 27.58 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | - | - | 0.06 | Upgrade
|
| Other Unusual Items | 0 | 0 | 0.04 | - | 0.18 | 0.03 | Upgrade
|
| Pretax Income | 9.18 | 7.07 | 52.62 | 40.89 | 32.18 | 27.67 | Upgrade
|
| Income Tax Expense | 4.1 | 3.47 | 11.97 | 1.63 | -9.21 | 7.42 | Upgrade
|
| Net Income | 5.08 | 3.61 | 40.65 | 39.26 | 41.39 | 20.25 | Upgrade
|
| Net Income to Common | 5.08 | 3.61 | 40.65 | 39.26 | 41.39 | 20.25 | Upgrade
|
| Net Income Growth | -82.13% | -91.13% | 3.54% | -5.15% | 104.35% | 27.14% | Upgrade
|
| Shares Outstanding (Basic) | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | Upgrade
|
| Shares Outstanding (Diluted) | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | Upgrade
|
| EPS (Basic) | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| EPS Growth | -82.12% | -91.13% | 3.71% | -5.31% | 104.85% | 27.18% | Upgrade
|
| Free Cash Flow | 3.92 | -18.2 | 49.41 | 22.61 | -32.04 | -80.18 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.01 | 0.03 | 0.01 | -0.02 | -0.05 | Upgrade
|
| Dividend Per Share | 0.002 | 0.002 | 0.005 | 0.004 | 0.003 | 0.002 | Upgrade
|
| Dividend Growth | -61.96% | -61.96% | 16.65% | 51.97% | 24.74% | 9.98% | Upgrade
|
| Gross Margin | 32.20% | 31.73% | 39.84% | 40.46% | 36.05% | 34.57% | Upgrade
|
| Operating Margin | 4.01% | 3.53% | 16.56% | 15.10% | 13.16% | 12.85% | Upgrade
|
| Profit Margin | 1.40% | 1.04% | 11.73% | 12.60% | 16.98% | 10.08% | Upgrade
|
| Free Cash Flow Margin | 1.08% | -5.27% | 14.26% | 7.26% | -13.15% | -39.89% | Upgrade
|
| EBITDA | 41.36 | 37.81 | 80.28 | 68.43 | 44.62 | 36.02 | Upgrade
|
| EBITDA Margin | 11.36% | 10.94% | 23.17% | 21.96% | 18.30% | 17.92% | Upgrade
|
| D&A For EBITDA | 26.74 | 25.6 | 22.92 | 21.38 | 12.54 | 10.19 | Upgrade
|
| EBIT | 14.61 | 12.21 | 57.36 | 47.05 | 32.09 | 25.84 | Upgrade
|
| EBIT Margin | 4.01% | 3.53% | 16.56% | 15.10% | 13.16% | 12.85% | Upgrade
|
| Effective Tax Rate | 44.63% | 49.01% | 22.75% | 3.99% | - | 26.81% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.